Synairgen PLC (SNG)

Industry Biotechnology
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

6.02p

Buy

7.48p

arrow-up0.40p (+6.06%)

Prices updated at 19 Apr 2024, 09:16 BST
| Prices minimum 15 mins delay
|
Prices in GBX
Synairgen PLC is a respiratory drug discovery and development company. It is engaged in the drug discovery and development of therapies for respiratory diseases, particularly in the areas, including severe asthma, chronic obstructive pulmonary disease.
FTSE All-Share
arrow-down-0.64%
LSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
6.60
triangle-d
arrow-up
1.40 (+21.21%)
triangle-d
Today open
8.00
triangle-d
arrow-down
-1.00 (-12.50%)
triangle-d
Today, 09:16:29 BST
7.00
triangle-d
8.00p - 6.30p
14.90p - 4.00p
-
13.29m
-
30,000
102,807
0.83
343,244.62
1.40
201.37m
GB00B0381Z20
-0.05
-
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.